Page 7890
Mar 6, 2020
NASA Awards Launch Services Contract for the Psyche Mission
Posted by Roderick Reilly in category: space travel
NASA has selected SpaceX of Hawthorne, California, to provide launch services for the agency’s Psyche mission. The Psyche mission currently is targeted to launch in July 2022 on a Falcon Heavy rocket from Launch Complex 39A at Cape Canaveral Air Force Station in Florida.
NASA has selected SpaceX of Hawthorne, California, to provide launch services for the agency’s The total cost for NASA to launch Psyche and the secondary payloads is approximately $117 million, which includes the launch service and other mission related costs.
The Psyche mission will journey to a unique metal-rich asteroid, also named Psyche, which orbits the Sun between Mars and Jupiter. The asteroid is considered unique, as it appears to largely be made of the exposed nickel-iron core of an early planet – one of the building blocks of our solar system.
Mar 6, 2020
The EARN IT Act Is a Sneak Attack on Encryption
Posted by Brent Ellman in category: encryption
Mar 6, 2020
See Curiosity’s Highest-Resolution Panorama of Mars Yet
Posted by Genevieve Klien in category: space
If news from Earth has got you down, maybe this update from the Red Planet will take your mind off things. NASA’s Curiosity rover mission has produced an incredible 1.8-billion-pixel image of the surface of Mars.
The image above doesn’t nearly do it justice, so be sure to watch the video below. You can also use this NASA webpage to explore the panorama in detail.
Mar 6, 2020
Tesla Solar Roof: Elon Musk-shared image reveals its best feature
Posted by Genevieve Klien in categories: Elon Musk, sustainability, transportation
Mar 6, 2020
Music therapy for stroke patients ‘improves brain and motor function’
Posted by Genevieve Klien in categories: biotech/medical, media & arts, neuroscience
Music therapy can help improve brain and motor function in stroke patients, scientists say.
A new study has found taking part in music sessions can boost mood and improve concentration in patients recovering from stroke. Those participating in the two-year sessions alongside existing stroke rehabilitation treatment also reported physical benefits such as better arm function and gait.
Based on their trials, the researchers are preparing a proposal for an NHS-funded permanent music therapy sessions post on the stroke ward at the Addenbrooke’s hospital in Cambridge, where the study was conducted.
Mar 6, 2020
The first coronavirus vaccine could be in ‘clinical use’ in April
Posted by Prem Vijaywargi in categories: biotech/medical, health
China has said that some vaccines for the novel coronavirus could be in clinical use next month as the number of global coronavirus cases soared past 100,000.
The country’s scientists are striving to develop immunisation products with five technologies simultaneously, according to officials.
Continue reading “The first coronavirus vaccine could be in ‘clinical use’ in April” »
Mar 6, 2020
Emotions Are Represented In The Brain In A Surprisingly Similar Way To Visual Information, Study Argues
Posted by Genevieve Klien in category: neuroscience
By Emma Young. Researchers recorded participants’ brain activity and emotions while they watched Forrest Gump.
Mar 6, 2020
The Mediterranean nearly dried up. A cataclysmic flood revived it
Posted by Genevieve Klien in category: futurism
New evidence reignites a longstanding debate about how the sea reconnected with the ocean.
Mar 6, 2020
Edited bone marrow cells trigger “striking” tumor regression in mice
Posted by Genevieve Klien in categories: biotech/medical, neuroscience
Immunotherapy is an increasingly powerful form of cancer treatment where the patient’s own immune system is equipped with heightened abilities to take down the disease, and one promising arm of this is known as adoptive cell therapy. This involves using altered versions of a patient’s own cells to trigger a more strong-handed response from their own immune system. Scientists at Johns Hopkins Kimmel Cancer Center are reporting an exciting advance in this area, demonstrating that engineered bone marrow cells can slow the growth of prostate and pancreatic cancers in mice.
The study builds on previous research where scientists demonstrated that a range of cancers, including melanomas, colon cancer and brain cancer, grow much more slowly in mice that are lacking a certain gene, known as p50, which seems to activate a stronger immune response. The Johns Hopkins researchers sought to further validate these earlier findings, while expanding the utility of a promising form of cancer therapy.
To do this, the team worked with what are known as immature myeloid cells, a type of white blood cell, which previous research had indicated could help switch on immune responses that fight tumors. In this case, the immature myeloid cells were taken from the bone marrow of mice engineered to lack the p50 gene, as a way of comparing them to the behavior of cells taken from mice who had the p50 gene in tact.
